Skip to content
Search

Latest Stories

New repeat prescribing toolkit to improve patient care, reduce medicine waste

New repeat prescribing toolkit to improve patient care, reduce medicine waste

By streamlining repeat prescribing systems, the RPS/RCGP toolkit aims to reduce the impact of overprescribing and problematic polypharmacy

The Royal Pharmaceutical Society (RPS) and the Royal College of GPs (RCGP) have launched a new toolkit to enhance the consistency, safety, and efficiency of repeat prescribing systems in general practices across England.

Commissioned by NHS England, this toolkit is the first national good practice guidance for repeat prescribing in two decades and aims to address issues highlighted by the 2021 National Overprescribing Review.


The review recognised the impact that poorly operated repeat prescribing can have on overprescribing and problematic polypharmacy.

Over 1 billion prescriptions are dispensed annually in England, 77% of which are repeat prescriptions, which account for nearly 80% of NHS primary care medicine costs.

The sheer volume and workload of repeat prescriptions underscore the need for streamlined and improved processes.

The RPS/RCGP Repeat Prescribing Toolkit allows GP practice teams and primary care networks, working in collaboration with community pharmacies and patients, to create a “collaborative, safe and efficient” repeat prescribing process.

This approach aims to enhance patient care by addressing inconsistencies and potential oversupply, whilst reducing unnecessary medicines waste and saving NHS resources.

Clare Howard, RPS Fellow and Clinical Lead author, noted that this toolkit marks a significant step forward in ensuring the safety and efficiency of repeat prescribing systems, ultimately benefiting patients and the NHS as a whole.

“By working together, the RPS and RCGP have developed practical guidance and useful resources which will enable GP practices and Primary Care Networks to self-assess their current arrangements and make meaningful improvements in their repeat prescribing processes,” she explained.

The toolkit also includes practical guidance on improving communication with patients about repeat prescribing, supported by good practice case studies, flow charts, action plan templates, and useful resources.

Dr Michael Mulholland, Honorary Secretary of the RCGP, emphasised that safe and appropriate prescribing is a key skill for GPs, and they take it “very seriously”

“Repeat prescribing makes up a large part of the general practice workload and we need to make sure we are always streamlining and improving the process,” he said.

To complement the toolkit, a new NHS dashboard has been developed to highlight potential oversupply of medicines in various prescribing areas. The dashboard will support improvement initiatives, particularly by identifying inconsistencies in repeat prescribing processes, to help minimise avoidable waste and the risk of patient harm.

Graham Prestwich, patient representative and Board Member at Healthwatch Leeds, stated that the toolkit and associated resources will help make communicating with patients about their repeat medicines “simpler and more effective."

Professor Tony Avery, National Clinical Director for Prescribing at NHS England, emphasised the importance of the tool, stating: “With over one billion prescriptions dispensed annually in England, over three quarters of which are repeat prescriptions, it is essential that repeat prescribing systems in general practices are safe for patients and efficient for all involved.”

The toolkit is now available for use by general practices, Primary Care Networks, Integrated Care Boards, and community pharmacies across England.

More For You

Infant formula: Food, diet and obesity committee welcomes CMA proposals, demands action on processed foods
CMA study shows that parents could save around £300 a year by switching to a lower priced infant formula brand (gettyimages)

Infant formula: CMA calls for stronger labelling and advertising rules

All infant formula brands should be displayed together and separately from other formula milks in stores to enable quick and easy price comparisons – suggests CMA 

The Competition and Marketing Authority (CMA) has recommended the governments of the four UK nations to strengthen advertising and labelling rules of infant formula to help parents make informed decisions and save money.

This follows a CMA study on infant formula and follow-on milks, which found that a combination of factors was leading to poor outcomes for parents.

Keep ReadingShow less
David Thomas Steps In as NPA’s New Wales Representative
Five NPA members are contesting for the remaining position in England (gettyimages)

NPA board update: David Thomas succeeds Raj Aggarwal OBE

Five NPA members are contesting for the remaining position in England

David Thomas, owner of LT Chemists in Newport, will replace Raj Aggarwal OBE as the next National Pharmacy Association (NPA) board member for Wales, following an uncontested election this month.

Following the conclusion of a nomination process last week, Baldev Bange, Aisling O’Brien, Sehar Shahid, and Sanjay Ganvir have been re-elected to the Board, representing areas of England and Scotland, according to a statement from NPA.

Keep ReadingShow less
Public Policy Projects calls for better use of community pharmacy skill mix to improve medicines adherence
Non-adherence to medicines remains a critical issue, with an estimated 30 to 50 per cent of medicines for long-term conditions not taken as prescribed. (gettyimages)

Leverage pharmacy skill mix to improve medicines adherence - report suggests

The report also suggested expanding the community pharmacy contractual framework to enable community pharmacy to deliver medicines reviews

Pharmacy technicians and assistants should be enabled to talk to patients about their medications to improve medicines adherence, a new report has recommended.

The report, How medicines optimisation contributes to population health, published recently by policy institute Public Policy Projects, highlighted that non-adherence to medicines remains a critical issue, with an estimated 30 to 50 per cent of medicines for long-term conditions not taken as prescribed.

Keep ReadingShow less
GHP calls for 10% mandated protected learning time for NHS pharmacists in new campaign
Many pharmacists end up doing ‘unpaid work’ to catch up with the required training (gettyimages)

Increase protected learning time for NHS pharmacists – GHP launches national campaign

Many pharmacists end up doing ‘unpaid work’ to catch up with the required training or completing self-learning in their own time.

The Guild of Healthcare Pharmacists (GHP) has launched a national campaign advocating for pharmacists working in the NHS to have a minimum of 10% of their contracted hours protected for supporting professional activities (SPA).

In a statement published on 7 February 2025, the GHP emphasised that this protected time “should be recognized by employers and embedded in job plans.”

Keep ReadingShow less
Pharmacy contract consultation to review medicine margin and reimbursement, says Kinnock

Pharmacy contract consultation to review medicine margin and reimbursement, says Kinnock

Kinnock confirms that an announcement on the 2025/26 GP contract would be made before April 2025

The 2025/26 pharmacy contract consultation will include a review of the medicine margin and reimbursement arrangements, health and care minister Stephen Kinnock has confirmed.

Kinnock made this statement in response to a written question from Nick Timothy, Conservative MP for West Suffolk, who asked the secretary of state for health and social care, if he will review the reimbursement system for pharmacies and GP practices dispensing medicines.

Keep ReadingShow less